Found 716 clinical trials
UPENN Case Test Study New Logic 1 (Do Not Make Any Changes)
UPENN Case Test Study New Logic 1 (Do Not Make Any Changes)
- 0 views
- 16 Jun, 2025
UPENN Case Test Study New Logic 4 (Do Not Make Any Changes)
UPENN Case Test Study New Logic 4 (Do Not Make Any Changes)
- 0 views
- 16 Jun, 2025
- 1 location
Study for Translations (Do not make changes-AI)
Study for Translations (Do not make changes)
- 0 views
- 28 Aug, 2025
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy (FMTB Brij)
The goal of this randomized, prospective, interventional clinical trial is to evaluate the use of Brijjit® in reducing the incidence of hypertrophic scarring in individuals undergoing gender-affirming bilateral double incision mastectomies at a single-institution, single-surgeon site (Esther A. Kim, MD). Patients will serve as a self-control (one side of the …
- 0 views
- 28 Aug, 2025
Study of Lademirsen (SAR339375) in Patients With Alport Syndrome
Primary Objectives: To assess the efficacy of lademirsen (SAR339375) in reducing the decline in renal function To assess the safety and tolerability of lademirsen (SAR339375) in subjects with Alport syndrome Secondary Objectives: To assess plasma pharmacokinetic (PK) parameters of the parent compound and its metabolites To assess the potential formation …
- 0 views
- 29 Nov, 2024
- 20 locations
ZEUS A research study to see how Ziltivekimab works compared to placebo in patients with cardiovascular disease, chronic kidney disease and inflammation (ZEUS)
The purpose of this study is to see if the new study drug, Ziltivekimab, can be used to treat people with cardiovascular disease, chronic kidney disease, and inflammation. The ZEUS study will see if Ziltivekimab can reduce the risk of having cardiovascular events (for example, heart attack and stroke). The …
- 0 views
- 03 May, 2025
- 1 location
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …
- 0 views
- 15 Sep, 2025